Détail de l'auteur
Documents disponibles écrits par cet auteur
trié(s) par (Pertinence décroissant(e), Date de parution décroissant(e), Date de parution décroissant(e), Système de projection du document croissant(e)) Mettre toutes les notices dans le panier Faire une suggestion Ajouter un critère de recherche
Synaptotagmin 13 is neuroprotective across motor neuron diseases
Nizzardo M, Taiana M, Rizzo F, et al.
Acta neuropathologica, 2020
Animal models of CMT2A: state-of-art and therapeutic implications
De Gioia R, Citterio G, Abati E, et al.
Molecular neurobiology, 2020
Disease Modeling and Therapeutic Strategies in CMT2A: State of the Art
Barbullushi K, Abati E, Rizzo F, et al.
Molecular neurobiology, 2019
Genome-wide RNA-seq of iPSC-derived motor neurons indicates selective cytoskeletal perturbation in Brown-Vialetto disease that is partially rescued by riboflavin
Rizzo F, Ramirez A, Compagnucci C, et al.
Scientific Reports, 2017, 7
Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model
Nizzardo M, Simone C, Rizzo F, et al.
Science advance, 2015, 1, 2
Effect of combined systemic and local morpholino treatment on the spinal muscular atrophy delta7 mouse model phenotype
Nizzardo M, Simone C, Salani S, et al.
Clinical Therapeutics, 2014, 36, 3, p 340
iPSC-Derived Neural Stem Cells Act via Kinase Inhibition to Exert Neuroprotective Effects in Spinal Muscular Atrophy with Respiratory Distress Type 1
Simone C, Nizzardo M, Rizzo F, et al.
Stem cell reports, 2014, 3, 2, p 297
Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy
Corti S, Nizzardo M, Simone C, et al.
Science translational medicine, 2012, 4, 165, 165ra162, 15 p.
